Disease management: State of the art and future directions

Clinical Therapeutics

Volumn 21, Issue 3, 1999, Pages 593-609

  Armstrong, Edward P ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Disease management; Evidence based medicine; Managed care; Outcomes research

Indexed keywords

CLINICAL PROTOCOL; COST BENEFIT ANALYSIS; DECISION MAKING; DRUG COST; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; MANAGED CARE; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; TREATMENT PLANNING;

EID: 0032949174     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)88312-5     Document Type: Article

References (38)

1. 1. Harris JM. Disease management: New wine in new bottles? Ann Intern Med. 1996;124:838-842.
2. 2. Epstein RS, Sherwood LM. From outcomes research to disease management: A guide for the perplexed. Ann Intern Med. 1996;124:832-837.
3. 3. Woolf SH. Practice guidelines: A new reality in medicine. I. Recent developments. Arch Intern Med. 1990;150:1811-1818.
4. 4. Todd WE, Nash D, eds. Disease Management. A Systems Approach to Improving Patient Outcomes. Chicago: American Hospital Publishing; 1997.
5. 5. Summers KH. Measuring and monitoring outcomes of disease management programs. Clin Ther. 1996:18:1341-1348.
6. 6. Byrnes J. Does disease management really work? The Lovelace Health Systems experience. Dis Manage Health Outcomes. 1998;1:39-53.
7. TM: Results from a 1-year study. Dis Manage Health Outcomes. 1998;1:3-12.
8. 8. Ellrodt G, Cook DJ, Lee J, et al. Evidence-based disease management. JAMA. 1997; 278:1687-1692.
9. 9. Armstrong EP, Langley PC. Disease management programs. Am J Health-Syst Pharm. 1996;53:53-58.
10. 10. Freeman DA, Britton ML, Letassy NA, et al. Management of hyperlipidemia in a clinical pathway unit. Dis Manage Health Outcomes. 1998;1:111-120.
11. 11. Anonymous. Medicaid to pay Mississippi pharmacists for disease management. State board deliberates credentialing process. Am J Health-Syst Pharm. 1998; 55:1238-1239.
12. 12. Selby JV. Linking automated databases for research in managed care sellings. Ann Intern Med. 1997;127:719-724.
13. 13. Motheral BR, Fairman KA. The use of claims databases for outcomes research: Rationale, challenges, and strategies. Clin Ther. 1997;19:346-366.
14. 14. Armstrong EP. Monitoring and evaluating disease management: Information requirements. Clin Ther. 1996;18:1327-1333.
15. 15. Wert SM. A disease management case study in infectious disease. Clin Ther. 1996;18:1366-1373.
16. 16. Goldberg HI, Wagner EH, Fihn SD, et al. A randomized controlled trial of CQI teams and academic detailing: Can they alter compliance with guidelines? J Qual Improve. 1998;24:130-142.
17. 17. Knutson DJ. Disease management con tracting: Key elements. Clin Ther. 1996; 18:1349-1355.
18. 18. Algozzine T, Pannone R, Kozma CM. Opinions of disease management programs among medical directors of managed care organizations. Am J Health-Syst Pharm. 1998;55:1029-1033.
19. 19. Langley PC. Assessing the input costs of disease management programs. Clin Ther. 1996;18:1334-1340.
20. 20. Tilney CK, Whiting SB, Horrar JL, et al. Improved clinical and financial outcomes associated with a comprehensive congestive heart failure program. Dis Manage Health Outcomes. 1998;1:175-183.
21. 21. Doxtator RF, Rodriguez DJ. Evaluating costs, benefits, and return on investment for disease management programs. Dis Manage Health Outcomes. 1998;1:185-192.
22. 22. Perry S, Marx ES. Practice guidelines: Role of economics and physicians. Health Aff. 1994;13:141-145.
23. 23. Liang MH, Shadick N. Feasibility and utility of adding disease-specific outcome measures to administrative databases to improve disease management. Ann Intern Med. 1997;127:739-742.
24. 24. Holdford DA. Barriers to disease management. Am J Health-Syst Pharm. 1996; 53:2093-2096.
25. 25. Armstrong EP, Manuchehri F. Ambulatory care databases for managed care organizations. Am J Health-Syst Pharm. 1997; 54:1973-1983.
26. 26. Barr CE. The role of information technology in disease management: Supporting identification and delivery of best practices. Dis Manage Health Outcomes. 1998; 1:121-134.
27. 27. Legorreta AP, Christian-Herman J, O'Connor RD, et al. Compliance with national asthma management guidelines and specialty care. A health maintenance organization experience. Arch Intern Med. 1998;158:457-464.
28. 28. Gasdek Manolakis P, ed. APhA Guide to Drug Treatment Protocols: A Resource for Creating and Using Disease-Specific Pathways. Washington, DC: American Pharmaceutical Association; 1998:2-1-4-7.
29. 29. Eddy DM. Practice policies: Where do they come from? JAMA. 1990;263:1265-1275.
30. 30. Eddy DM. Resolving conflicts in practice policies. JAMA. 1990;264:389-391.
31. 31. Eield MJ, Lohr KN, eds. Guidelines for Clinical Practice. From Development to Use. Washington, DC: National Academy Press; 1994:346-410.
32. 32. Guyatt GH, Cook DJ, Sackett DL, et al. Grades of recommendation for anti-thrombotic agents. Chest. 1998;114(Suppl): 441S-444S.
33. 33. Audet AM, Greenfield S, Field M. Medical practice guidelines: Current activities and future directions. Ann Intern Med. 1990;113:709-714.
34. 34. Olson CM. Consensus statements: Applying structure. JAMA. 1995;273:72-73.
35. 35. Woolf SH. Practice guidelines, a new reality in medicine. II. Methods of developing guidelines. Arch Intern Med. 1992; 152:946-952.
36. 36. Spain M. The operational elements of developing a congestive heart failure clinic. Dis Manage Health Outcomes. 1998;1: 77-83.
37. 37. Curtis FR. Lessons learned from projects in disease management in ambulatory care. Am J Health-Syst Pharm. 1997;54: 2217-2229.
38. 38. Brunner L, Hickey ME. Disease management: Lovelace Health Systems episodes of care - a case study. Best Pract Benchmarking Healthcare. 1997;2:254-257.